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ProliferationWnt signaling has been implicated in somite, limb, and branchial arch myogenesis but the mechanisms and
roles are not clear. We now show that Wnt signaling via Lef1 acts to regulate the number of premyogenic
cells in somites but does not regulate myogenic initiation in the limb bud or maintenance in the ﬁrst or
second branchial arch. We have also analysed the function and regulation of a putative downstream
transcriptional target of canonical Wnt signaling, Pitx2. We show that loss-of-function of Pitx2 decreases the
number of myogenic cells in the somite, whereas overexpression increases myocyte number particularly in
the epaxial region of the myotome. Increased numbers of mitotic cells were observed following
overexpression of Pitx2 or an activated form of Lef1, suggesting an effect on cell proliferation. In addition,
we show that Pitx2 expression is regulated by canonical Wnt signaling in the epaxial somite and second
branchial arch, but not in the limb or the ﬁrst branchial arch. These results suggest that Wnt/Lef1 signaling
regulates epaxial myogenesis via Pitx2 but that this link is uncoupled in other regions of the body,
emphasizing the unique molecular networks that control the development of various muscles in vertebrates.
© 2009 Elsevier Inc. All rights reserved.Introduction
During vertebrate embryogenesis, the striated musculature of the
head and trunk arises from two distinct regions: the somitic
mesoderm gives rise to the axial, appendicular, and tongue muscu-
lature whilst the unsegmented paraxial mesoderm, together with the
prechordal plate, forms the majority of the craniofacial musculature.
These distinct origins are also reﬂected by different molecular
signatures, for example, the axial skeletal musculature expresses the
transcription factor Pax3, which is essential for myogenesis, but the
developing craniofacial musculature does not (Bajard et al., 2006;
Bothe and Dietrich, 2006; Brunelli et al., 2007; Buckingham and
Relaix, 2007) reviewed in Noden and Francis-West (2006). Despite
these differences, commitment to the myogenic pathway in all
regions of the body is controlled by myogenic regulatory factors
(MRFs) Myf5, MyoD, Mrf4, and myogenin (Rudnicki et al., 1993;
Tajbakhsh et al., 1996). This is followed by terminal differentiation
characterised by the expression of myosin heavy chains (MyHC).
In response to extrinsic patterning signals, each somite divides
into two main compartments: a dorso-lateral epithelial compartment
called the dermomyotome and a ventral mesenchymal compartment
called the sclerotome, the progenitor of the vertebrae and ribs. The. Francis-West),
ll rights reserved.dermomyotome is a transient structure, which contributes cells to the
epaxial and hypaxial myotome in successive phases. The primary
myotome is generated by cells that enter ﬁrst from the medial
dermomyotome border, in a second phase myocytes are produced
from all four dermomyotome edges. Finally, the central portion of the
dermomyotome undergoes an epithelial-to-mesenchymal transition
(EMT) leading to an inﬂux of muscle progenitor cells into the primary
myotome (Gros et al., 2004; Manceau et al., 2008). Recent work has
shown that the expansion of the latter population of myogenic
progenitors is inﬂuenced by notch and myostatin signaling, which
affects their terminal differentiation (Manceau et al., 2008; Schuster-
Gossler et al., 2007; Vasyutina et al., 2007). The limb and tongue
musculature arises by delamination of the hypaxial dermomyotome
in response to hepatocyte growth factor signaling and myogenic cells
migrate to their ﬁnal destination (Dietrich, 1999). Within the
developing limb bud, they become committed to the myogenic
lineage and form the dorsal and ventral muscle masses.
The Wnt family of growth factors play key roles during embryonic
myogenesis. Early studies demonstrated that a combination of Shh
protein and Wnt1 or Wnt3a-expressing ﬁbroblasts is sufﬁcient to
activate skeletal muscle-speciﬁc gene expression in explants of somites
or presegmented mesoderm (Münsterberg et al., 1995). Wnt signaling
has also subsequently been implicated inmyogenic commitmentwithin
the developing limb bud; however, it has been shown to be inhibitory
for craniofacialmyogenesis (Anakwe et al., 2003; Geetha-Loganathan et
al., 2005; Tzahor et al., 2003). The Wnt ligands can signal through a
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planar cell polarity and calcium pathways (reviewed by Gordon and
Nusse, 2006). Thebest characterised is thepathway involvingβ-catenin,
the glycogen-synthase kinase 3β (GSK3β) destruction complex and the
T-cell factor/lymphoid enhancing factor-1 (Tcf/Lef1) transcription
factors. In an uninduced cell, β-catenin is phosphorylated and removed
by theGSK3βdestruction complex andTcf/Lef1, togetherwithGroucho,
acts as a transcriptional repressor. However, Wnt binding to the
serpentine frizzled receptor results in the inhibition of the GSK-3β
destruction complex allowing the accumulation of β-catenin, which is
subsequently translocated to the nucleus. Here, β-catenin binding
converts Tcf/Lef1 to a transcriptional activator (reviewed by Stadeli et
al., 2006;Willert and Jones, 2006). CanonicalWnt signalingalso requires
a co-receptor, the low-density lipoprotein receptor-related proteins 5
and 6 (LRP5/6) (Niehrs, 2006).
Wnt signaling is modulated by a number of antagonists including
extracellular antagonists such as the secreted frizzled related
proteins/frizbees (Sfrps/Frzb) and Dkk1. The Sfrps have homology
to the extracellular domain of the frizzled receptors and bind to Wnt
proteins preventing their binding to the frizzled receptors. The Sfrps
are, therefore, not speciﬁc to a particular Wnt pathway. In contrast,
Dkk1 acts by binding directly to the extracellular domain of LRP-5/6
and therefore interferes speciﬁcally with canonical Wnt signaling.
The canonical Wnt signaling pathway is essential for the develop-
ment of the epaxial musculature, consistent with the expression of β-
catenin andLef1 in thedorso-medial lip of thedermomyotome (Schmidt
et al., 2004; Schmidt et al., 2000). The importance of Wnt signaling for
the activation of myogenesis is further illustrated by the ﬁnding that
transplacental delivery of Frzb1 inhibits somite myogenesis. This study
suggested that Wnt signals may act by regulating both myogenic
commitment and expansion of committed cells (Borello et al., 1999). In
addition, the detailed analyses of Myf5 regulatory elements revealed
important Tcf/Lef sequences, whichmediate the correct spatiotemporal
expression of Myf5 in the epaxial domain of the somite (Borello et al.,
2006; Teboul et al., 2002). Consistent with this, experiments using
targeted electroporation of activated β-catenin showed that Wnt/β-
catenin signaling is crucial for myogenic speciﬁcation (Gros et al., 2009).
The transcription factor, Pitx2, is a target of theβ-catenin-dependent
Wnt pathway (Kioussi et al., 2002). Pitx2 can also be an effector of this
pathway, for example, in epithelial cells it forms a functional complex
with β-catenin and Lef1 to synergistically induce transcription from the
Lef1 promoter (Amen et al., 2007; Vadlamudi et al., 2005), thus
establishing a positive feedback loop. It is known that Pitx2, Pitx1, and
Pitx3, are expressed in the developing musculature (Dong et al., 2006;
Golding et al., 2004; Poulin et al., 2000; Shih et al., 2007a,b). Pitx2 has
been shown to regulate proliferation in cardiac neural crest cells, the
pituitary gland, and the myogenic cell lines, C2C12 and Sol8 (Kioussi et
al., 2002; Martinez-Fernandez et al., 2006). In the ﬁrst branchial arch,
Pitx2 overexpression increases the number of differentiating myocytes.
Pitx2 also regulates cell survival, as gene inactivation in mice results in
the apoptosis of ﬁrst branchial arch myogenic cells (Dong et al., 2006;
Shih et al., 2007a).
Here, we examined the relationship between Lef1 and Pitx2 and
show that Pitx2 expression is regulated by Wnt/Lef1 signaling in the
myotome and second branchial arch. In addition, we investigated the
function of Lef1 and Pitx2 during somite and limb myogenesis.
Materials and methods
Embryo manipulations, RCAS infection, electroporation, and bead implants
Fertile white Leghorn chicken eggs were obtained from Henry
Stuart (Lincolnshire) and incubated at 37.5 °C and were staged
according to Hamburger and Hamilton (HH) (Hamburger and
Hamilton, 1992). Stage 12 embryos were used for retrovirus (RCAS)
infection and embryos at HH16were used for somite electroporations.After manipulations, eggs were sealed and incubated for 24 or
48 hours, depending on the experiment. Embryos were harvested in
DEPC PBS, ﬁxed overnight in 4% paraformaldehyde at 4 °C, and
processed for in situ hybridisation. The timing of somite infections
should predominantly affect the primary myotome.
Concentrated retrovirus was prepared following standard proto-
cols (Morgan and Fekete, 1996). The following RCAS constructs were
used: RCAS-ΔNLef1, RCAS-ΔNLef1-VP16, RCAS-ΔN34Lef1, RCAS-
Pitx2a, RCAS-Pitx2a-En, and RCAS-GFP. Pitx2 viruses were kindly
provided by Yi-Ping Chen (Tulane University, New Orleans; Yu et al.,
2001). Concentrated RCAS virus was injected into presegmented
mesoderm of HH stage 12 embryos and the embryos were allowed to
develop for 48 hours before harvesting. The contralateral, uninfected
side, and/or RCAS-GFP-infected somites served as control. The spread
of infection was examined using in situ detection of viral gag mRNA.
Alternatively, pellets of O-line cells infected with the retroviruses
were grafted into the developing limb bud at stages 17/18 and
embryos were allowed to develop until day 8 (Anakwe et al., 2003).
Electroporation was carried out as described in Sweetman et al.
(2008). Brieﬂy, HH16 epithelial somites 2–6 were injected with
plasmid DNA at a concentration of 1.5 mg/ml. Positive and negative
platinum electrodes were kept 2 mm apart and placed on either side
of the somites. A TSS20 Ovodyne electroporator (Intracel) was used to
apply 5 pulses of 15 V for 15ms. PBS buffer was added before and after
electroporation.
For the Dkk1 manipulation studies, afﬁgel beads were soaked in
500 ng/μl solution of recombinant mouse Dkk1 protein (carrier-free,
R&D Systems) for 1 hour at 37 °C. They were applied to either the ﬁrst
or the second branchial arches or the developing limb buds at HH
stages 20/21 of embryonic development. Control beads were soaked
in 0.1% BSA in PBS. The embryos were allowed to develop for 24 hours
and were then analysed for changes in gene expression by whole-
mount in situ hybridisation.
Micromass cultures
Micromass cultures from HH stage 19/20 chick wing buds were
prepared as described (Anakwe et al., 2003). Brieﬂy, the ectoderm was
dissociated from the limb mesenchyme in 2% trypsin and the
mesenchymal cells were disaggregated to a single-cell suspension. A
total of 2×105 cells were resuspended in 10 μl of concentrated RCAS
retrovirus and plated as a droplet. After 1 hour, the micromass cultures
were ﬂooded with DMEM containing 10% FCS, 1% chick serum, 1%
penicillin/streptomycin. Micromasses were cultured for 3 days, ﬁxed in
methanol for 1minute at room temperature and analysed for Pan-MyHC
expression using the A4.1025 antibody (DSHB). Each assay consisted of
at least 3micromasses and theexperimentswereperformed in triplicate.
Statistical signiﬁcance was determined using the Student's t-test.
In situ hybridisation and immunohistochemistry
Whole-mount in situ hybridisations were carried out as previously
described (Anakwe et al., 2003; Schmidt et al., 2000). Anti-sense Lef1,
Pitx2, MyoD, Myf5, Mgn, MyoR, Pax3, Pax7, and anti-gag probes were
used (Dastjerdi et al., 2007; Smith et al., 2005; Yu et al., 2001). After in
situ hybridisation, embryos were ﬁxed in 4% PFA, washed with PBS,
and transferred into gelatin for vibratome sectioning or into 30%
sucrose/PBS and ﬁnally OCT for cryosectioning and immunoanalysis.
Ten-micrometer sections were subjected to a double immunostaining
using phospho-histoneH3 andMF-20 antibodies (DSHB, 1:500). Brieﬂy,
sections were incubated with 0.1% Triton and treated with 1:10 H2O2/
PBS for 10minutes. Afterwashing twice in PBS, sectionswere blocked in
10% goat serum and primary antibody was applied overnight at 4 °C.
Sections were blocked in 10% goat serum before applying secondary
antibodies, anti-rabbit Alexa Fluor 488 to detect phospho-histone H3
(green) (Molecular Probes), at 1:1000. Sectionswere treated with DAPI
to stain nuclei and mounted in Mowiol. Pictures were taken on an
Axioscope microscope using Axiovision software (Zeiss, Germany).
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The number of phospho-histone H3-positive cells was counted in
the dermomyotomes and myotomes of RCAS-ΔNLef1-VP16- or RCAS-
Pitx2a-infected and contralateral, non-infected somites. SPSS was
used to calculatemeans and standard errors. Counts from infected and
non-infected sides were treated as paired readings (Lef1, n=137,
Pitx2, n=47) and statistical analysis was carried out to conﬁrm the
signiﬁcance of the observed differences (Wilcoxon test).
Results
Canonical Wnt signaling via Lef1 affects the size of the myotome
Wnt signaling via β-catenin promotes myogenesis. In order to
elucidate its role in more detail we infected presegmented mesoderm
at HH12with RCAS retrovirus expressing amutant form of Lef1, RCAS-
ΔNLef1, which retains the HMG box that binds to DNA, but lacks the
β-catenin co-activator and Groucho co-repressor binding domains
(Fig. 1G). One side of the embryo was targeted allowing the
contralateral side to be used as control. After 48 hours, successfulFig. 1. Manipulating Lef1 activity in somites affects the number of myogenic cells. The pre
expressing ΔN-Lef1 (A–C′), ΔNLef1-VP16 (D–F′), ΔN34-Lef1 (H–J′), the structure of the pr
transcripts (A) (dark purple) conﬁrmed efﬁcient transfection of somites. Double in situ hybri
of cells expressing Pax-7 (B), Pax-3 (D), MyoD (C, E), and Mgn (A, F) increased on the ma
misexpression of ΔN34-Lef1 decreased the number of cells expressing MyoD (H), Mgn (I) an
corresponding sections are shown, except (I′), which shows another example similar to (I) a
regions, gag probe was developed with INT/BCIP or Fast Red (red) with the myogenic mark
Mgn is turquoise (BCIP).transfection and targeting was determined by in situ detection of viral
gag transcripts (Figs. 1A and A′). Effects of ΔNLef1 on myogenic
differentiation were investigated by in situ hybridisation analyses of a
series of marker genes. This showed that transfected somites had a
thickened myotome characterised by an increased number of cells
expressing Pax-7, a premyogenic marker gene (n=12; Figs. 1B and B′).
In addition, expression of the myogenic bHLH transcription factors,
MyoD (n=17) andmyogenin (n=7)was increased on the transfected
side (Figs. 1A, A′, C, and C′). As the ΔN-Lef1 amino-terminal deletion
protein cannot interact with the Groucho co-repressor, these results
are consistent with the idea that loss of Lef1-mediated repression was
sufﬁcient to activate myogenesis. Furthermore, the increased number
of cells expressing Pax-7 and Pax-3 suggests that Wnt signaling via
Lef1 acts early during myogenic speciﬁcation.
To extend these observations, we used the same deletion construct
fused to the strong transcriptional activator VP16 (Fig. 1G). ΔNLef1-
VP16 was targeted to the developing somite by RCAS-mediated
infection (Figs. 1D–F). Alternatively, newly formed epithelial somites
were electroporated with an expression vector, pCAβ encoding the
same protein: ΔNLef1-VP16. The pCAβ vector also expresses GFP from
an IRES (Supplemental Figs. 1A–D). After 24 hours, in situ detection ofsegmented mesoderm of chicken embryos was infected with avian retrovirus (RCAS)
oteins expressed are indicated schematically in (G). In situ hybridization for viral gag
dization was performed with gag and a panel of markers. This showed that the number
nipulated side after targeted misexpression of ΔNLef1 and ΔNLef1-VP16. In contrast,
d Myf-5 (J). The probes used are indicated above each panel, whole-mount embryos and
nd (J′) which shows the contralateral side of (J). The black arrows indicate the affected
er in NBT/BCIP (purple), except in (A, F) where gag is shown in purple (NBT/BCIP) and
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tal Figs. 1A and A′). The phenotype observed with ΔNLef1-VP16 was
similar to that observed with ΔNLef1. Sections through the trans-
fected region showed that ΔNLef1-VP16 resulted in increased
expression of premyogenic markers Pax-3 (n=6; Figs. 1D and D′),
Pax7 (n=3; data not shown) and myogenic markers MyoD (n=9;
Figs. 1E and E′) andMgn (n=8; Figs. 1F and F′). The same results were
obtained after electroporation of pCAβ-ΔNLef1-VP16 (Supplemental
Figs. 1A–D); however, phenotypes after RCAS-mediated overexpres-
sion were usually stronger than after electroporation.
Next, we examined the effects of loss of Lef1-mediated transcrip-
tional activation on myogenesis by targeted misexpression of RCAS-
ΔN34-Lef1. In this deletion, the β-catenin binding domain was
speciﬁcally removed, whilst the binding domain for the Groucho co-
repressor was retained, leading to a dominant negative effect (Fig.
1G). Expression of RCAS-ΔN34-Lef1 in presegmented mesoderm
resulted in a marked decrease ofMyoD (n=11; Figs. 1H and H′),Mgn
(n=10; Figs. 1I and I′), andMyf5 (n=11; Figs. 1J and J′) in somites on
the infected side of the embryo.
Lef1 interacts with Pitx2 to regulate myogenic differentiation in somites
Pitx2 is a direct transcriptional target of the Wnt–β-catenin
signaling; in addition, it acts with Lef1 to regulate the Lef1 promoter,
creating a positive feedback loop (Ai et al., 2007; Amen et al., 2007;
Vadlamudi et al., 2005). In the mouse embryo, Pitx2 is expressed in the
developing myotome, branchial arch mesoderm, and limb myogenic
cells (Kioussi et al., 2002; L'Honore et al., 2007; Marcil et al., 2003; Shih
et al., 2007b). Expression of Pitx2 in chick embryonicmusculature has, to
date, only been reported in the branchial arches (Dong et al., 2006).
Therefore, to investigate a potential interaction of Pitx2with Lef1 during
somite myogenesis, we analysed Pitx2 expression in chick somites.
Pitx2 transcripts were ﬁrst detected in the hypaxial myotome of
HH20 embryos (Fig. 2A). By HH22, Pitx2 was expressed in committed
myogenic cells throughout the myotome, but with lower levels in the
central region (Figs. 2B and B′). In posterior somites, expression was
still limited to the hypaxial domain (Fig. 2B). Expression of Pitx2 is
overlapping with MRFs, Lef1, Tcf1, and β-catenin (Schmidt et al.,
2004), and to investigate the relationship between canonical WntFig. 2. Targeted misexpression of RCAS-ΔNLef1-VP16 or RCAS-ΔN34-Lef1 increased or decre
cells. Whole-mount in situ hybridization was performed with the probes indicated above e
arrowheads), by HH22 Pitx2 expression was seen throughout the myotome except in poster
Infection with RCAS-ΔNLef1-VP16 (C) resulted in an increase of Pitx2 transcripts particularly
(D) resulted in loss of Pitx2 transcripts particularly in the epaxial and central myotomes (D
transcripts (E, F) particularly in the epaxial and central myotomes (E′, F′ black arrows). Infect
was developed with INT/BCIP or Fast Red (red) or BCIP (light blue); other probes were develo
in the insets. Relevant sections are shown below the whole mounts (B′–G′); (H′) shows cosignaling and Pitx2 during embryonic myogenesis, we examined the
effects of RCAS-ΔNLef1-VP16 and RCAS-ΔN34Lef1 on Pitx2 expression
in developing somites (Figs. 2C–D′). Targeted misexpression of
ΔNLef1-VP16 by RCAS infection of epithelial somites at HH17 led to
an increase in Pitx2 transcripts, particularly in the epaxial myotome
(n=16) (Figs. 2C and C′). In contrast, infection with a retrovirus
encoding ΔN34Lef1 caused reduced Pitx2 expression (n=7) (Figs. 2D
and D′). The negative effect of ΔN34Lef1 on Pitx2 expression was seen
in epaxial and central myotomes, but not in the hypaxial domain.
To examinewhether Lef1may affect themyotomevia Pitx2, at least in
part, we determined the phenotypes resulting from RCAS-mediated
expression of either a Pitx2a full-length protein or Pitx2a-En where the
engrailed repressor is fused to Pitx2a (Figs. 2E–H). Targeted expression of
Pitx2a resulted in a dramatic increase inmyotome thickness as indicated
by expression of MyoD (n=14) and Mgn (n=13) (Figs. 2E–F′). The
phenotype was most apparent in, but not limited to, the epaxial
myotome. Conversely, RCAS-Pitx2a-En resulted in a loss of transcripts
for themyogenicmarkersMyf5 (n=12, not shown),MyoD (n=20), and
Mgn (n=4), throughout myotomes (Figs. 2G–H′).
Lef-1 and Pitx-2 expression increased cell proliferation in dermomyotomes
and myotomes
Next we investigated the potential mechanism by which Lef1 and
Pitx2a affect the size of the myotome. In particular, we determined
whether proliferation of myogenic cells could be affected in
developing somites, as has been demonstrated previously for Pitx2a
in cardiac neural crest cells and the myogenic satellite C2C12 and Sol8
cell lines (Kioussi et al., 2002; Martinez-Fernandez et al., 2006).
Labelling with phospho-histone-H3 was used to quantify the number
of mitotic cells 48 hours after transfection with RCAS-ΔN-Lef1 (Fig.
3A) or RCAS-Pitx2a (Fig. 3C). The position of the myotome was
identiﬁed in brightﬁeld images and the number of mitotic cells within
infected dermomyotomes and myotomes was counted and compared
with the number of mitotic cells in non-infected contralateral somites
(Figs. 3B and D). After infection with RCAS-ΔNLef1 or RCAS-Pitx2a
more cells in mitosis were detected (30%), suggesting that prolifer-
ation may be increased (Fig. 3 compare panels A and B with C and D;
Fig. 3E, Pb0.01). This conclusion is supported by the overall increaseased the myotomal expression of Pitx2 and Pitx2 itself affects the number of myogenic
ach panel. At HH20, Pitx2 transcripts were detected in hypaxial myotomes (A, white
ior somites (B, B′). (C–H) Double whole-mount in situ hybridization with Pitx2 and gag.
in the epaxial and central myotomes (C′ black arrows). Infection with RCAS-ΔN34-Lef1
′ black arrows). Infection with RCAS-Pitx2a resulted in an increase of MyoD and Mgn
ion with RCAS-Pitx2a-En resulted in loss of MyoD andMgn transcripts (G, H). Gag probe
ped with NBT/BCIP (purple). Lateral views are shown in (A–H)with dorsal view shown
ntralateral control. so, somite; hyp, hypaxial mytome; epi, epaxial myotome.
Fig. 3. Targeted misexpression of ΔN-Lef1 or Pitx2a led to an increased number of mitotic cells in the dermomyotome and myotome. Brightﬁeld and ﬂuorescent images of sections
(10 μm) are shown. (A, B) Infection of presegmented mesoderm with RCAS-ΔN-Lef1 resulted in an increase of mitotic cells, stained with anti-phospho-histone H3, compare the
infected (A″) with the contralateral side (B″). (C, D) Infection of presegmented mesoderm with RCAS-Pitx2a resulted in an increase of mitotic cells, stained with anti-phospho-
histone H3; compare the infected (C″) with the contralateral side (D″). RCAS-gag transcript was detected by in situ hybridization (A, C; INT/BCIP, red). Sections were stained with
DAPI (A′–D′, blue) or anti-phospho-histone H3 (A″–D″, green). SPSS analysis conﬁrmed that the differences in themeans of paired counting (n=137 for Lef1, n=47 for Pitx2a) were
statistically signiﬁcant (Pb0.01). The diagram in (E) shows a graphical representation of this data. The dotted lines indicate the dermomyotome and myotome area.
215M. Abu-Elmagd et al. / Developmental Biology 337 (2010) 211–219in myotome size. The statistical signiﬁcance of the observed
differences was conﬁrmed using the SPSS Wilcoxon test (number of
sections counted/paired counting: ΔNLef1, n=137; Pitx2, n=47).
The molecular regulation of limb and branchial arch myogenesis differs
from somite myogenesis
In the limb bud, the temporal and spatial expression pattern of
Pitx2 is consistent with that previously reported in themouse (Kioussi
et al., 2002; L'Honore et al., 2007;Marcil et al., 2003; Shih et al., 2007b)
(Supplemental Fig. 2). Pitx2 transcripts were ﬁrst observed at stage 21.
Comparison of MyoD versus Pitx2 expression on adjacent sections
through limb buds showed that the Pitx2 expression domain
encompasses both that of MyoD and Pax3 (Supplemental Figs. 2D
and E). This indicates that Pitx2 is expressed in developing myogenic
cells both prior to and after myogenic commitment (Supplemental
Figs. 2A, B, D, and E). This is in contrast to the somite where Pitx2 is
expressed after myogenic commitment.The previous experiments showed that Lef1/Pitx2 regulates
myogenesis within the somite and we provided evidence that
proliferation of myogenic progenitors is affected. As myogenesis is
differentially controlled in different regions of the body, we extended
our analysis to the developing limbs and branchial arches (Fig. 4). First,
we analysed possible effects of canonical Wnt signaling on Pitx2
expression. Application of beads soaked in Dkk1, an antagonist that
speciﬁcally blocks this pathway, did not alter Pitx2 expression in the
limb bud (Fig. 4A, n=6). Likewise, infection of the limb buds with
RCAS retrovirus expressing dominant negative ΔN34-Lef1 had no
effect on Pitx2 expression (n=5, Figs. 2O and P). However, RCAS-
ΔNLef1 infection of limb buds led to a slight increase in Pitx2
transcripts (Figs. 4M and N; n=3). These ﬁndings suggest that Wnt
signaling can positively affect Pitx2 expression in the limb bud
mesenchyme; however, it is not required.
To further investigate the relationship between Pitx2 and limb
myogenesis together with the role of the canonical Wnt pathway
during limb myogenic differentiation, we analysed the expression of
Fig. 4.Manipulation ofWnt signaling does not affect limb or branchial archmyogenesis. (A–C) Beads soaked in Dkk-1were implanted into the limb bud at HH19–20, and after 24 hours,
embryoswere processed for in situhybridization for (A) Pitx2, (B)Myf-5, and (C)MyoD. (D–P) RCAS infection of embryos followed bywhole-mount in situhybridization for the indicated
markers. (D)Detectionof viral transcripts demonstrates successful infectionof limbbuds. Active Lef1 (E, F)ordominant-negative Lef1 (G,H)hasnoeffect onmyogenicmarkers. Dominant-
negative Lef1 did not affect Pitx2 expression (O, P); however, active Lef1 slightly increased Pitx2 transcripts (M,N). Targetedmisexpressionof Pitx2a (I, J) or thedominant-negative Pitx2a-
En (K, L) had no effect onmyogenic gene expression (I–L). (Q–X) Chick embryos showing expression of indicatedmarkers in the manipulated and contralateral control branchial arch 24
hours after application of aDkk1 soakedbead (indicated byawhite arrowhead). Q–Vare lateral views of the control (Q, S, U) andmanipulated (R, T, V) archwhilstW, X show frontal views.
(Y, Y’) Analysis of an E9.5 TOPGAL reportermouse embryo that has been stained for LacZ activity. (Y) Lateral view of the head showing labelling in the ﬁrst and second branchial (ba) arch.
Mesodermal expression is arrowed. (Y’) Frontal sectionof 1/2 of the embryo shown inY showing expression in theneural crest derivedmesenchyme in theﬁrst branchial arch (ba1) and in
the mesoderm of the second branchial arch (ba2). Probes used are indicated on each panel, control=contralateral limb, RCAS=infected limb.
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inhibition of Wnt signaling by misexpression of ΔNLef1 or ΔN34Lef1
proteins (Figs. 4E–H; n=4, n=7). Alternatively we applied Dkk1
beads (Figs. 4B and C). These studies demonstrated that myogenic
commitment within the limb bud is not regulated by the canonical
Wnt pathway (Dkk1: Myf5, n=5; MyoD, n=5), a conclusion
consistent with recent studies in the mouse (Hutcheson et al., 2009).
To determine whether Pitx2, which in limb bud mesenchyme
seemed to be Wnt-independent, could affect myogenesis, we used
RCAS to misexpress Pitx2a (Figs. 4I and J; n=30) or Pitx2a-En (Figs.
4K and L; n=16). Embryos were harvested 48 hours after infection.
At this time, we could not detect any differences in expression of
MyoD and Mgn transcripts between infected and non-infected limb
buds, suggesting that limb bud myogenesis was independent of
Pitx2a, at least in the early phase.
We also extended these studies to the branchial arches, where
myogenic differentiation is differentially regulated. In the head,
application of Dkk1 soaked beads inhibited Pitx2 expression in the
second, but not in the ﬁrst, branchial arch mesoderm and ectoderm
(Figs. 4W and X), indicating that canonical Wnt signaling may be
involved. This was consistent with analysis of the TOPGAL reporter
mouse at E9.5, which showed LacZ reporter activity, indicative of
canonical Wnt signaling, within the mesoderm of the second but not
the ﬁrst branchial arch (Figs. 4Y and Y′). However, as in the limb bud,
application of Dkk1 beads did not alter the expression of myogenic
markers (Figs. 4Q–V; ba1: Myf5, n=7; MyoD, n=8; MyoR, n=1; ba
2: Myf5, n=2; MyoD, n=3; MyoR, n=3).Late myogenic differentiation in the limb is affected by Pitx2
Although we did not detect an effect of Pitx2 on early limb
myogenesis, we have previously shown that Pitx2 determines the
number of terminally differentiated myocytes in the ﬁrst branchial
arch (Dong et al., 2006). Therefore, we next investigated a potential
role of Pitx2 during terminal myogenic differentiation in the limb bud.
RCAS(BP) retroviruses encoding either Pitx2a-En or Pitx2a proteins
were used to infect developing limb cells in micromass cultures, a
simple assay which allows quantiﬁcation of myocyte differentiation
(Figs. 5G and H). Limb bud cells were isolated fromHH19/20 embryos
and plated at a high density in the presence of high-titer RCAS
retrovirus. Terminal myogenic differentiation was determined after
3 days by staining with the pan-MyHC antibody. The effect of both
isoforms of Pitx2, Pitx2a and Pitx2c, was examined, as it has been
shown that these can have differential effects (Yu et al., 2001). In the
micromass assay, misexpression of Pitx2a or Pitx2c signiﬁcantly
increased the number of differentiated myocytes compared to RCAS-
GFP-infected controls. In contrast, blocking Pitx2a or Pitx2c function
had the converse effect and reduced myocyte number signiﬁcantly
(Figs. 5G and H; Pb0.05).
We extended this in vitro analysis to in vivo studies. Here we
grafted pellets of RCAS-infected cells into a HH18/19 limb bud. This
results in viral spread throughout the majority of the limb (Duprez et
al., 1996). RCAS-infected embryos were incubated until day 8 of
development when primary myogenesis is complete. The limbs were
ﬁxed and immunostained with the pan-MyHC antibody to analyse
Fig. 5. Pitx2 regulates myogenic differentiation in the limb bud. (G) Fluorescent images of micromass cultures infected with retroviruses encoding Pitx2a and Pitx2c or dominant-
negative Pitx2a and Pitx2c constructs. The micromasses were stained with 1025, a pan-MyHC antibody, to visualise the myocytes. (H) Quantiﬁcation of the number of myocytes in
the micromass cultures (⁎Pb0.05, ⁎⁎⁎Pb0.005). (A–F) Fluorescent images of transverse cryosections of control (A, C, E) and retrovirally infected (B, D, F) day 8 chick wings infected
with RCAS expressing GFP, ΔPitx2a, or Pitx2a and labelled with the pan-MyHC 1025 antibody. Sections were taken at the same level of the chick wing. The arrows indicate the
location of the Anc muscle. In the Pitx2a-En-infected limb, the Anc muscle is absent and the EDC and EMRmuscles are decreased in size. In the Pitx2a-infected limb, the Anc, EIL, EDC
and EMRmuscles are increased in size. Anc, anconeus; EDC, extensor digitorum communis; EIL, extensor indicis longus; EMR, extensor metacarpi radialis; EMU, extensor metacarpi
ulnaris; FDP, ﬂexor digitorum profundus; PP, pronator profundus; PS, pronator superﬁcialis.
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uninfected contralateral limb. The number of myoﬁbers was counted
every 40 μm through the zeugopod of the limb and the ﬂexor and
extensor muscles were analysed separately. We found that blocking
Pitx2a function in vivo by expressing Pitx2a-En virus reduced the
number of differentiated myocytes/myoﬁbers (Figs. 5C and D; n=4
limbs; average number in control extensormuscles, n=159 versus 77
in infected extensor muscles, Pb0.01; average number control ﬂexor
muscles, n=280 versus 234 in infected ﬂexor muscles, Pb0.01).
Conversely, overexpression of Pitx2a signiﬁcantly increased the
number of differentiated myocytes/myoﬁbers and hence increased
muscle size (Figs. 5E and F; ﬂexormuscles: control n=265 versus 339
in the infected side, Pb0.05; extensor muscles, control, n=158 versus
219 in infected limbs, Pb0.01). Infection with the control GFP virus
did not signiﬁcantly alter the number ofmyoﬁbers or patterning of the
muscles (extensors, control, n=162 versus GFP-infected, n=158,
Figs. 5A and B). This demonstrated that within the limb bud, Pitx2
affected the number of myocytes/myoﬁbers and thus ﬁnal muscle
size.
Discussion
The canonical Wnt signaling pathway has been implicated in
epaxial, limb and branchial arch myogenesis: in the epaxial somiteand limb bud Wnt signaling has been proposed to be involved in
myogenic commitment whereas in the head, it has been shown to be
inhibitory (reviewed by Noden and Francis-West, 2006). Here, we
have uncovered differential requirements and functions of Wnt/Pitx2
in these regions and identiﬁed the stages in the myogenic pathway
when canonical signaling acts. By targeted misexpression of the
ΔNLef1 mutant construct, we uncover that de-repression of canonical
Wnt signaling is sufﬁcient to promote myogenesis in the somite (Figs.
1A–C). Strong activation of somite myogenesis was also observed
following RCAS-ΔNLef1-VP16 infection consistent with the documen-
ted effect of canonical Wnt signaling on myogenic commitment
(Borello et al., 2006; Gros et al., 2009). Interestingly, the increased
expression of the myogenic markers, Pax-7 and Pax-3, suggests that
Wnt/Lef1 may act early during myogenic commitment at least in
somites. In the limb and branchial arch muscles, however, manipula-
tion of Lef1 activity or application of the Wnt antagonist, Dkk1,
showed that myogenic commitment/maintenance does not require
the canonical Wnt signaling pathway (Fig. 4). This is in keeping with
observations reported in transgenic mice, where conditional activa-
tion or inactivation of β-catenin was used to demonstrate that early
and late limb muscle progenitors have distinct requirements for β-
catenin (Hutcheson et al., 2009).
We also analysed the expression and function of a putative
downstream target of canonical Wnt signaling, Pitx2, which in
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transcription (Vadlamudi et al., 2005). We have shown that Pitx2 is
regulated by the canonical Wnt pathway in the epaxial somite and
second branchial arch, but not in the ﬁrst branchial arch (Figs. 2 and
4). However, in all regions, misexpression of Pitx2 increases the
number of myogenic cells (Figs. 2 and 5; Dong et al., 2006).
We previously proposed that canonical Wnt signaling may
regulate myogenic differentiation in the developing limb bud.
Evidence to support this was the ability of the dominant-negative
Lef1 construct to reduce myocyte number as assayed by the
expression of MyHC chain when misexpressed in limb cultures
(Anakwe et al., 2003). Furthermore, the Wnt antagonist, Sfrp2,
reduced myocyte number in vivo and in vitro (Anakwe et al. 2003).
Here, we show that canonical Wnt signaling does not regulate MyoD
or Myf5 expression in developing limb buds, indicating that, in
contrast to the epaxial musculature of somites, limbmyogenesis is not
initiated via the Wnt/β-catenin pathway. Therefore, the role of
canonical Wnt signaling in the development of the embryonic limb
musculature is presently unclear and may occur at later stages of
differentiation after myogenic commitment. Alternatively, canonical
Wnt signaling may regulate cell proliferation and/or survival.
Inhibition of Wnt signaling in the early cranial paraxial mesoderm
results in the premature and ectopic activation of MyoD expression
(Tzahor et al., 2003). The Wnt inhibition studies reported here in
which we show that the expression of MyoD, together withMyf5 and
MyoR (Fig. 4) is not regulated by canonical Wnt signaling at ﬁrst
appear to be at odds with the previous study. There are two obvious
explanations for this discrepancy. First, myogenic cells in the proximal
versus distal ﬁrst branchial arch have distinct molecular signatures
reﬂecting their different origins; the cranial paraxial and lateral
splanchnic mesoderm, respectively (Nathan et al., 2008). These
distinct regions may be differentially controlled by the canonical
Wnt pathway: to date, it has been shown that the distal musculature
is regulated by Wnt signaling at early stages (8–10) of development
(Nathan et al., 2008). The studies described here focus on the
proximal region. Second, the experiments presented here were at a
later stage of development (stage 20/21 versus stage 8/10).
Regardless of the explanation for the differences, what the data
does conclusively show is that once myogenic commitment is
initiated within the proximal branchial arch, canonical Wnt signaling
is not required to maintain myogenic differentiation.
The Pitx2 promoter contains Tcf/Lef binding sites and expression
can be induced by LiCl, which activates the canonical Wnt signaling
pathway (Vadlamudi et al., 2005). Our analysis here shows that Pitx2
expression is differentially regulated by Wnt/Lef1 signaling in the
different regions of the body: canonical Wnt signaling does control
Pitx2 expression in the epaxial myotome (Figs. 2C and D) and in the
second branchial arch mesoderm and ectoderm (Figs. 4W–Y), but is
not required for Pitx2 expression in the ﬁrst branchial arch (Fig. 4W).
In the developing limb bud, we have found that RCAS-ΔNLef-VP16 at
early stages led to upregulation of Pitx2 in infected forelimb buds
(Figs. 4M and N); however, implanting Dkk1-inhibitor beads at HH
stage 20/21 did not result in loss of Pitx2 expression (Fig. 4A). This
suggests that migratory muscle progenitors are sensitive to increased
Wnt signaling, whereas differentiating myoblasts no longer require
Wnt to maintain Pitx2 expression.
Targeted misexpression was used to examine the function of Pitx2
in somites and limb buds. This showed that Pitx2 is important for
primary myogenesis, in particular in the epaxial somite. Both Lef1-
VP16 and Pitx2 infection increased the number of myogenic cells
(Figs. 1, 2, and 5). The effects observed with Pitx2-En and Pitx2a are
highly reminiscent of those seen following the manipulation of Wnt/
Lef1 signaling. We considered the following possibilities for how Lef1
and Pitx2 may regulate myogenic cell number. Pitx2 and Lef1 may
increase the number of myogenic cells by (a) increasing commitment
of premyogenic cells to the myogenic lineage, (b) promoting cellproliferation, and/or (c) decreasing apoptosis. There is no evidence of
signiﬁcant apoptosis within the developing dermomyotome and
myotome, thus making the last scenario unlikely. However, the ﬁrst
scenario is consistent with our ﬁnding that targeted misexpression of
activated or de-repressed Lef1 mutant proteins (ΔN-Lef1-VP16, ΔN-
Lef1), i.e., activation of the canonical Wnt pathway, increased the
number of cells expressing early myogenic markers (Figs. 1B and D;
Supplemental Fig. 1B). Counting the number of mitotic, phospho-
histone H3-positive cells in the dermomyotome and myotome
suggests that canonical Wnt signaling via Lef1 and Pitx2 also
stimulates the proliferation of myogenic progenitor cells by 30%
(Fig. 3), which overall leads to a thickenedmyotome. A previous study
showed that Wnt-3a regulates proliferation in HH10 somite explants.
These authors also showed that ectopic expression of Wnt-3a in the
neural tube in vivo results in enhanced proliferation of dorsal/
dermomyotomal cells and the subsequent expansion of the dermo-
myotome and myotome (Galli et al., 2004). Our results are consistent
with this and further demonstrate that Lef1 and Pitx2 are the effectors
of Wnt signaling cues. Other recent studies have implicated roles for
the notch signaling pathway and myostatin in controlling the balance
between proliferation and differentiation of secondary myogenic
progenitors that invade the primary myotome following the epithe-
lial-to-mesenchymal transition of the central part of the dermomyo-
tome. Mutations led to premature differentiation and thus the
depletion of the progenitor pool, resulting in muscle hypotrophy
(Manceau et al., 2008; Schuster-Gossler et al., 2007; Vasyutina et al.,
2007). Together with the data presented here, this indicates that
different pathways are involved in regulating the number of primary
and secondary myogenic progenitor cells.
The ability of Pitx2 to increase proliferation, in part by inducing the
expression of cell cycle regulators such as cyclin D1 and D2, has
previously been shown in cardiac cells and in the Sol8 and C2C12
myogenic cell lines (Kioussi et al., 2002; Martinez-Fernandez et al.,
2006). Pitx2 is also expressed in proliferating satellite cells, the
progenitor cells of the adult musculature (data not shown). Therefore,
a unifying theme of Pitx2 appears to be to increase proliferation.
Analysis of the Pitx2 null mouse embryo has shown that in the
absence of Pitx2, differentiation of the ﬁrst branchial arch muscula-
ture, but not the second branchial arch, is affected (Dong et al., 2006;
Shih et al., 2007a). This demonstrated that differential molecular
programmes regulate myogenesis in the ﬁrst and second branchial
arch and is consistent with the identiﬁcation of an enhancer that
initiates Myf5 expression speciﬁcally in the second branchial arch
(Summerbell et al. 2000). The Dkk1 bead implants (Fig. 4) also seem
to uncouple a role for Pitx2 andmyogenic differentiation in the second
branchial arch mesoderm.
Overall, this study provides insight into the molecular players
downstream of Wnt signaling, which are involved in embryonic
myogenesis, and uncovers some striking differences in different
muscle groups.
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